The Centers for Disease Control and Prevention yesterday alerted health care providers and the public to reports of severe illness associated with using products containing ivermectin to prevent or treat COVID-19. While ivermectin is approved by the Food and Drug Administration to treat infections caused by parasites, it is not authorized or approved to prevent or treat COVID-19. Dispensing of ivermectin by retail pharmacies and calls to poison control centers involving the drug have increased sharply during the pandemic, however. In some cases, people have ingested products purchased without a prescription, including topical formulations and veterinary products, CDC said. Clinical effects of ivermectin poisoning can range from gastrointestinal symptoms to hypotension and neurological effects.

Related News Articles

Headline
Commenting on a forthcoming Centers for Medicare & Medicaid Services’ rule requiring COVID-19 vaccinations for workers in most health care settings…
Chairperson's File
On this episode, I discuss emergency preparedness, caregiver resiliency and health equity — all through the lens of the COVID-19 pandemic — with Fritz Francois…
Headline
The Centers for Medicare & Medicaid Services today announced that the agency will pay for Medicare beneficiaries’ booster doses, without cost sharing…
Headline
AHA today urged the Office of the United States Trade Representative to extend the current Section 301 tariff exemptions for certain medical devices to ensure…
Headline
The Centers for Disease Control and Prevention early Friday morning opted for a broad endorsement of Pfizer COVID-19 vaccine booster shots, issuing interim…
Headline
The AHA today urged the Health Resources and Services Administration to quickly distribute the $17 billion in Phase 4 provider relief funds and $8.5 billion in…